Bioluminescence imaging (BLI) demonstrated that AXL-CAR T cells partially suppressed the pulmonary tumour in the majority of mice on day 38, whereas CD19-CAR T or PBS could not control tumour progression (Fig. 2h, i). The gene discussed is AXL; the disease is neoplasm.